Acid Reducer Tablet, Film Coated
NDC 67091-244
Product Information
Acid Reducer (ranitidine hydrochloride) is a ANDA-approved product labeled by Winco Foods, Llc. Ranitidine is known as an H2 blocker. It is supplied as a pink tablet, film coated for oral administration. This product entry covers the primary NDC 67091-244 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
OR;606
Code Structure Chart
Product Details
What is NDC 67091-244?
What are the uses of this product?
What are Active Ingredients of this product?
- RANITIDINE HYDROCHLORIDE 75 mg/1 - A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- RANITIDINE HYDROCHLORIDE (UNII: BK76465IHM)
- RANITIDINE (UNII: 884KT10YB7) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- HYPROMELLOSES (UNII: 3NXW29V3WO)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)
- TALC (UNII: 7SEV7J4R1U)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 312773 - ranitidine 75 MG Oral Tablet
- RxCUI: 312773 - ranitidine 75 MG (as ranitidine hydrochloride 84 MG) Oral Tablet
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.